OPT 3.5 (+2.64%)
US68386J2087BiotechnologyBiotechnology

Opthea (OPT) Stock Highlights

3.5 | +2.64%
2024-09-19 04:23:12
Opthea Ltd operates in one industry being the medical technology and healthcare. It is focused primarily on developing biological therapeutics for eye diseases. The company is developing a novel biologic therapy, OPT-302, for the treatment of eye diseases. Its products are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors C and D and R3 targets. Optheas development activities are based on an intellectual property portfolio covering key targets Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage.

Statistics

Range Today
3.45 3.69
Volume Today 26.6K
Range 1 Year
1.6 4.4
Volume 1 Year 5.32M
Range 3 Year
1.6 8.5
Volume 3 Year 8.21M
Range 10 Year
1.6 16.23
Volume 10 Year 20.54M

Highlights

Market Capitalization 501.17M (small)
Floating Shares 822.38M
Current Price 3.5
Price To Earnings -1.13
Price To Revenue 14.92K
Earnings Per Share -2.76
Payout Ratio 0%

Performance

Latest +2.64%
1 Month +32.08%
3 Months +84.21%
6 Months +1.45%
1 Year +75%
3 Years -55.07%
5 Years -68.33%
10 Years -68.33%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.